CORVEL CORP(NASDAQ:CRVL) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 6 out of 10 to CRVL. CRVL was compared to 108 industry peers in the Health Care Providers & Services industry. CRVL gets an excellent profitability rating and is at the same time showing great financial health properties. CRVL is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CRVL was profitable.

In the past year CRVL had a positive cash flow from operations.

In the past 5 years CRVL has always been profitable.

In the past 5 years CRVL always reported a positive cash flow from operatings.

1.2 Ratios

CRVL has a Return On Assets of 15.72%. This is amongst the best in the industry. CRVL outperforms 97.20% of its industry peers.

CRVL has a better Return On Equity (28.83%) than 95.33% of its industry peers.

The Return On Invested Capital of CRVL (26.38%) is better than 99.07% of its industry peers.

Measured over the past 3 years, the Average Return On Invested Capital for CRVL is significantly above the industry average of 8.27%.

		Industry Rank	Sector Rank
ROA	15.72%
ROE	28.83%
ROIC	26.38%

ROA(3y)16.54%

ROA(5y)14.38%

ROE(3y)31.63%

ROE(5y)28.18%

ROIC(3y)28.37%

ROIC(5y)24.01%

1.3 Margins

The Profit Margin of CRVL (9.64%) is better than 93.46% of its industry peers.

In the last couple of years the Profit Margin of CRVL has grown nicely.

Looking at the Operating Margin, with a value of 12.02%, CRVL belongs to the top of the industry, outperforming 86.92% of the companies in the same industry.

In the last couple of years the Operating Margin of CRVL has grown nicely.

CRVL's Gross Margin of 21.81% is in line compared to the rest of the industry. CRVL outperforms 44.86% of its industry peers.

CRVL's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	12.02%
PM (TTM)	9.64%
GM	21.81%

OM growth 3Y3.75%

OM growth 5Y2.98%

PM growth 3Y4.56%

PM growth 5Y4.11%

GM growth 3Y-1.18%

GM growth 5Y0.6%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CRVL is creating value.

Compared to 1 year ago, CRVL has more shares outstanding

Compared to 5 years ago, CRVL has more shares outstanding

There is no outstanding debt for CRVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CRVL has an Altman-Z score of 19.36. This indicates that CRVL is financially healthy and has little risk of bankruptcy at the moment.

CRVL has a better Altman-Z score (19.36) than 97.20% of its industry peers.

CRVL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	19.36

ROIC/WACC2.85

WACC9.25%

2.3 Liquidity

CRVL has a Current Ratio of 1.71. This is a normal value and indicates that CRVL is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Current ratio, with a value of 1.71, CRVL is in the better half of the industry, outperforming 60.75% of the companies in the same industry.

A Quick Ratio of 1.71 indicates that CRVL should not have too much problems paying its short term obligations.

CRVL's Quick ratio of 1.71 is fine compared to the rest of the industry. CRVL outperforms 63.55% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.71
Quick Ratio	1.71

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CRVL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.79%, which is quite good.

CRVL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.42% yearly.

Looking at the last year, CRVL shows a quite strong growth in Revenue. The Revenue has grown by 12.66% in the last year.

The Revenue has been growing slightly by 5.95% on average over the past years.

EPS 1Y (TTM)9.79%

EPS 3Y19.94%

EPS 5Y12.42%

EPS Q2Q%17.39%

Revenue 1Y (TTM)12.66%

Revenue growth 3Y12.9%

Revenue growth 5Y5.95%

Sales Q2Q%14.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 23.44, the valuation of CRVL can be described as rather expensive.

Based on the Price/Earnings ratio, CRVL is valued a bit cheaper than 67.29% of the companies in the same industry.

The average S&P500 Price/Earnings ratio is at 28.29. CRVL is around the same levels.

		Industry Rank	Sector Rank
PE	23.44
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRVL is on the same level as its industry peers.

The rest of the industry has a similar Price/Free Cash Flow ratio as CRVL.

		Industry Rank	Sector Rank
P/FCF	77.86
EV/EBITDA	42.72

4.3 Compensation for Growth

CRVL has an outstanding profitability rating, which may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)1.89

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CRVL!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CORVEL CORP

NASDAQ:CRVL (1/21/2025, 8:00:00 PM)

Premarket: 109.5 -0.89 (-0.81%)

110.39

+1.54 (+1.41%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)10-29 2024-10-29/bmo

Earnings (Next)02-04 2025-02-04

Inst Owners53.92%

Inst Owner Change0.5%

Ins Owners9.67%

Ins Owner Change-0.07%

Market Cap5.67B

Analysts0

Price TargetN/A

Short Float %N/A

Short Ratio19.19

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	23.44
Fwd PE	N/A
P/S	6.71
P/FCF	77.86
P/OCF	52.83
P/B	20.06
P/tB	23.12
EV/EBITDA	42.72

EPS(TTM)4.71

EY4.27%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)1.42

FCFY1.28%

OCF(TTM)2.09

OCFY1.89%

SpS16.46

BVpS5.5

TBVpS4.78

PEG (NY)N/A

PEG (5Y)1.89

Profitability

		Industry Rank	Sector Rank
ROA	15.72%
ROE	28.83%
ROCE	33.26%
ROIC	26.38%
ROICexc	48.2%
ROICexgc	62.08%
OM	12.02%
PM (TTM)	9.64%
GM	21.81%
FCFM	8.61%

ROA(3y)16.54%

ROA(5y)14.38%

ROE(3y)31.63%

ROE(5y)28.18%

ROIC(3y)28.37%

ROIC(5y)24.01%

ROICexc(3y)45.01%

ROICexc(5y)39.49%

ROICexgc(3y)59.7%

ROICexgc(5y)53.05%

ROCE(3y)35.76%

ROCE(5y)30.26%

ROICexcg growth 3Y1.94%

ROICexcg growth 5Y-3.26%

ROICexc growth 3Y6.17%

ROICexc growth 5Y0.54%

OM growth 3Y3.75%

OM growth 5Y2.98%

PM growth 3Y4.56%

PM growth 5Y4.11%

GM growth 3Y-1.18%

GM growth 5Y0.6%

F-Score6

Asset Turnover1.63

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	0
Cap/Depr	123.9%
Cap/Sales	4.08%
Interest Coverage	250
Cash Conversion	82.89%
Profit Quality	89.35%
Current Ratio	1.71
Quick Ratio	1.71
Altman-Z	19.36

F-Score6

WACC9.25%

ROIC/WACC2.85

Cap/Depr(3y)113.61%

Cap/Depr(5y)111.61%

Cap/Sales(3y)3.98%

Cap/Sales(5y)4.11%

Profit Quality(3y)77.48%

Profit Quality(5y)100.23%

High Growth Momentum

Growth

EPS 1Y (TTM)9.79%

EPS 3Y19.94%

EPS 5Y12.42%

EPS Q2Q%17.39%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)12.66%

Revenue growth 3Y12.9%

Revenue growth 5Y5.95%

Sales Q2Q%14.76%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y7.07%

EBIT growth 3Y17.13%

EBIT growth 5Y9.1%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y81.3%

FCF growth 3Y-3.19%

FCF growth 5Y2.01%

OCF growth 1Y49.57%

OCF growth 3Y1.69%

OCF growth 5Y4.76%

CORVEL CORP (CRVL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens